Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

90results about How to "Meet medication needs" patented technology

Effervescence dispersible tablet

The present invention relates to a new preparation of a Chinese medicine. The present invention particularly relates to a novel preparation of a drug with the effervescent tablet property and the dispersing agent property. In the effervescent dispersing tablet of the present invention, the weight ratio of each components are as following, which comprises 5 percentage to 60 percentage of effervescent agent, 3 percentage to 30 percentage of effervescing agent, 3 percentage to 30 percentage of disintegrant, 3 percentage to 30 percentage of excipient of the hydrophilic medicine, 1 percentage to 5 percentage of correctant. The effervescent dispersing tablet of the present invention is a novel preparation of the Chinese medicine, which has the effervescent tablet property and the dispersing agent property. The present medicine is a tablet, which can produce the gas in the water, which can disaggregate quickly and disperse evenly. The present invention is a novel preparation of the medicine, which can generate the gas; as a result the medicine can disaggregate more quickly. The drug loading dosage of the agent is large, which is beneficial for improving the dispersion uniformity, the dissolution and the bioavailability of the medicine. The present invention has the characteristics of convenience for oral administration and small dose. The present invention can sufficiently display the drug efficacy in order to meet the drug requirement of the patients.
Owner:YUNNAN BAIYAO GROUP

Recombinant expression vector for expressing LL-37 polypeptide, recombinant lactococcus lactis, antiviral drug, construction method and application

The invention provides a recombinant expression vector for expressing LL-37 polypeptide, recombinant lactococcus lactis, an antiviral drug, a construction method and application, and belongs to the technical field of gene engineering. A skeleton plasmid for constructing the recombinant expression vector is PNZ8149; a fusion gene is inserted into the recombinant expression vector; the nucleotide sequence of the fusion gene is shown as SEQ ID NO: 1. The recombinant expression vector disclosed by the invention can be efficiently expressed in lactococcus lactis, and the LL-37 obtained by expression can effectively inhibit SARS coronavirus and SARS-CoV2 coronavirus. The invention also provides recombinant lactococcus lactis containing the recombinant expression vector in the scheme. According to the recombinant lactococcus lactis disclosed by the invention, an antiviral polypeptide drug LL-37 can be input into a human body in an oral form, the antiviral effect is good, and the production cost is low.
Owner:INST OF ZOOLOGY CHINESE ACAD OF SCI

High-efficacy medicine supply method and device, medium, and electronic equipment

The invention provides a high-efficacy medicine supply method and device, a medium, and electronic equipment. The method comprises the steps: obtaining prescription information from each prescriptioninputted from a doctor's account, wherein the prescription information comprises the labels of medicines in the prescriptions and the account information of patients, so as to build the correspondingrelation between the medicines and the patients; receiving efficacy evaluation information which is inputted from the account of each patient and is corresponding to the labels of the medicines, so asto determine the efficacy of the medicines according to the evaluation of the patients; determining the high-efficacy medicine in all medicines according to the efficacy evaluation information corresponding to each medicine; determining the sum of the basic supply quantity and reserve quantity of the high-efficacy medicine as the inventory standard quantity of the high-efficacy medicine, determining the high-efficacy medicine according to the feedback of the patients, and carrying out the adjustment of the inventory standard quantity of the high-efficacy medicine, so as to enable the inventory of the high-efficacy medicine to meet the demands during the disease outbreak, and reduce the possibility of shortage of the high-efficacy medicine.
Owner:TAIKANG LIFE INSURANCE CO LTD

Semi-bionic preparation method for Xinkeshu preparations

The invention discloses a semi-bionic preparation method for Xinkeshu preparations. The preparation method comprises steps as follows: (1), costus roots are taken, ground, mixed with water, heated and subjected to reflux distillation, preliminary distillate is collected, redistillation is performed, volatile oil is extracted and the distillate is filtered; (2), other raw materials are taken and combined with medicine residues in the step (1), water with the pH (potential of hydrogen) value being 2.0-2.5 is added, and the mixture is heated, extracted and filtered; (3), water with the pH being 6.5-7.0 is added to medicine residues obtained in the step (2), and the mixture is heated, extracted and filtered; (4), water with the pH value being 7.8-8.5 is added to medicine dregs obtained in the step (3), and the mixture is heated, extracted and filtered; (5), filtrate obtained in the steps (2), (3) and (4) is combined and concentrated until an ointment is obtained, the ointment is granulated, dried and mixed with the volatile oil obtained in the step (1), a carrier or an auxiliary material acceptable in pharmaceutics is added, and medicine preparations are prepared. The content of effective ingredients of the Xinkeshu preparations prepared with the method is substantially increased, and the Xinkeshu preparations have higher bioavailability and are better absorbed by human bodies.
Owner:SHANDONG WOHUA PHARMACEUTICALS CO LTD

Tibetan-medicine three-component Tibet inula soup-granula composition and preparation process thereof

The invention relates to a Tibetan medicine, and particularly relates to a Tibetan-medicine three-component Tibet inula soup-granula composition and a preparation process thereof. The composition disclosed by the invention is prepared from the following raw materials in parts by weight: Ramulus Rubi, Tinospora sinensis and Tibet inula in a proportion of 2:1:1. The preparation process comprises the following steps: 1) carrying out superfine grinding on the Tibet inula; 2) placing the Tinospora sinensis and the Ramulus Rubi in a multifunctional extraction pot to decoct, filtering and concentrating to obtain an aqueous extract, and drying the aqueous extract by using a centrifugal spray drier; 3) combining dry cream powder with micro-powder; and 4) adding ethanol into the obtained powder, preparing into a soft material, granulating the soft material by using a granulator, drying, and carrying out straightening granulation to obtain the composition. According to the composition disclosed by the invention, when the quality of Tibetan medicines is improved, due to the reference and introduction of some new processes, new techniques and new devices, the stability and bioavailability of preparations can be improved, and traditional Tibetan medicine and modern preparation methods are combined, thus a way for the rational development of Tibetan medicines is explored.
Owner:多杰 +3

Preparation method of artificial bear gall powder preparation

The invention relates to the technical field of medicine production, in particular to a preparation method of an artificial bear gall powder preparation. The preparation method comprises the followingsteps of S1, preparing raw materials: poultry and livestock gall powder, beta cyclodextrin, cane sugar, dextrin, steviosin, menthol, peppermint oil, magnesium stearate, talcum powder, ethanol, starch, licorice root extractum powder, stevioside, PVA-4000, PVA-6000, glycerine, polyvinylpyrrolidone, hydroxypropyl methyl cellulose, hydroxyethyl cellulose, polyethylene glycol, dibutyl phthalate, a coloring agent and silicon dioxide; S2, dissolving the poultry and livestock gall powder with a buffered solution, performing centrifugation under the condition of 11000g, performing repeated filtrationto obtain filter residues and filtrate, and performing freeze drying and preservation on the filter residues; and S3, loading the filtrate in a reactor loaded with 7[alpha]-hydroxysteroid dehydrogenase. According to the preparation method disclosed by the invention, the artificial bear gall powder is designed to be a raw material medicine, and the artificial bear gall powder preparation is developed, so that the problem that natural bear gall raw materials are valuable and scarce is solved, and besides, a new medicine preparation is provided for human.
Owner:SHANGHAI KAIBAO PHARMA

Preparation method of artificial bear bile dripping pills

The invention relates to the technical field of medicines, in particular to a preparation method of artificial bear bile dripping pills. The preparation method comprises the following steps of S1, performing crushing, weighing and blending on raw materials: crushing artificial bear bile powder with a universal crushing machine, performing screening, and performing sealing for standby application;S2, performing compounding and heat preservation: heating oil bath to the temperature of 60-95 DEG C, adding polyethylene glycol 6000 to a blending jar in several times, wherein the addition quantityeach time is 2-20kg, performing heating and stirring for melting, after the polyethylene glycol completely melts, performing stirring, adding the crushed artificial bear bile powder, performing mixingto obtain cream which is dark pale brown to dark brown, and putting the compounded materials to be dripped in the blending jar for heat preservation; and S3, preparing dripping pills: adding 50-300kgof light weight liquid paraffin to a pill dripping machine as a condensing agent, wherein the temperature of oil bath in the pill dripping machine rises to 60-95 DEG C, adding materials to be drippedinto a seasoning jar, and performing dripping with 2.5# dripping heads of 1 row of dripping trays. According to the preparation method disclosed by the invention, the artificial bear bile powder is used as a raw material medicine, an artificial bear bile dripping pill preparation is developed, and the problem that natural bear bile raw materials are valuable and scarce is solved.
Owner:SHANGHAI KAIBAO PHARMA

Method for preparing FEIBA (factor eight inhibitor bypassing activity) from human plasma Cohn component III serving as raw material

ActiveCN105440127AYield will not changeEfficient use ofThrombomodulinPeptide preparation methodsWhole blood productElution
The invention relates to the pharmacy field of blood products, in particular to a method for preparing FEIBA (factor eight inhibitor bypassing activity) from a human plasma Cohn component III serving as a raw material. The method for preparing FEIBA from the human plasma Cohn component III serving as the raw material comprises steps as follows: (1), dissolution of the component III; (2), addition of a precipitator and centrifugalization; (3), inactivation of viruses; (4), gel adsorption; (5), washing and elution of gel; (6), condensation and solution replacement; (7) generation of FEIBA.
Owner:SHANGHAI RAAS BLOOD PRODUCTS CO LTD

Three-stage pulsed release controlled release tablet and preparation method thereof

The invention provides a metoprolol pulse osmotic pump controlled release tablet and a preparation method thereof. The controlled release tablet comprises a tablet core, a time lag coating layer and a controlled release coating layer with a release orifice from inside to outside, wherein the tablet core consists of a drug containing layer and a boosting layer, based on the gross weight of the drug containing layer, the drug containing layer comprises 5-65 wt% of metoprolol as active material and 35-95 wt% of pharmaceutically acceptable carrier; based on the gross weight of the boosting layer, the boosting layer comprises 30-85 wt% of swelling agent and 15-70 wt% of osmotic pressure promoting agent; the weight gain of the time lag coating layer is 5-50 wt% of the tablet core; and the weight gain of the controlled release coating layer is 3-30 wt% of the tablet core. The metoprolol pulse osmotic pump controlled release tablet has three-stage release behavior, and is characterized in that the tablet has 2-5 hours time lag at the initial period after being taken orally, increased release is showed at the intermediate period, and release at constant speed is showed at the later period.
Owner:CHINA RESOURCES DOUBLE CRANE PHARMA COMPANY

Control method, system and device for accurately applying pesticide to tobaccos and application

The invention belongs to the technical field of tobacco pesticide application control, and discloses a control method, system and device for accurately applying pesticide to tobaccos and application.A speed control wheel is used for accurately applying the pesticide to the tobaccos, and corresponding hardware devices and matched operation parameters are adopted for different development stages ofthe tobaccos; accessories such as a flow control main board, a multi-stage spray head and a horizontal auxiliary wheel are matched for use to reduce a spraying blank area or an invalid area of the prevention and treatment pesticide; an adjustable pressure pump determines the effective application range of the pesticide through the constant pesticide box pressure; the flow control device adjusts the pesticide flow at any time according to the change of the step speed of an operator through the step speed monitoring of the operator; the multi-stage spray head and the horizontal auxiliary wheelmeet the special requirements of pest control in different growth periods of the tobaccos; and the flow control mainboard only needs to input simple data information to complete parameter configuration of the whole system. The requirements of current precise pesticide application technicians, instruments, sites and the like are reduced, and the requirements of different tobacco planting productionareas can be met.
Owner:TOBACCO RES INST CHIN AGRI SCI ACAD

Medicine composition for preventing and treating respiratory system diseases, as well as preparation method and application thereof

The invention provides a medicine composition for preventing and treating respiratory system diseases. The medicine composition is an externally applied preparation prepared from the following raw materials and auxiliaries in parts by weight: 10-50 parts of semen brassicae, 10-50 parts of rhizoma corydalis, 5-40 parts of kansui roots, 5-40 parts of asarum, 50-300 parts of a disintegrating agent, 30-60 parts of adhesive and 2-15 parts of a lubricating agent. The invention further provides a preparation method and application of the medicine composition. The medicine composition is prepared from specific raw materials and auxiliaries in a specific dosage. Compared with a traditional acupoint application preparations, the medicine composition has the advantages of equivalent curative effect and convenience in use, can be used for remarkably reducing the drug irritation for skin and improving the acceptance of drug users, and can meet the medication requirement of patients. The medicine composition is simple in preparation process, low in cost and high in production efficiency, is available for volume production, and can meet the market requirement.
Owner:XIHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products